Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel

Clinical trial NCT06947668 · RECRUITING

Trial details

NCT number: NCT06947668
Sponsor: University of Erlangen-Nürnberg Medical School
Status: RECRUITING
Study type: OBSERVATIONAL

Squamous Cell Carcinoma of Oropharynx Squamous Cell Carcinoma of the Hypopharynx Larynx Squamous Cell Carcinoma Oral Cavity Squamous Cell Carcinoma

Start date: 2025-05-01
Primary completion: 2030-06-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.